Volume 1 issue 1, 2005 (not available)
Volume 1 issue 2, 2005. Expert Workshop on "Is Elimination of Minimal Residual Disease Significant for the Outcome of Chronic Lymphocytic Leukemia? The Role of Alemtuzumab (MabCampath®)"(Guest Editor: Michael Hallek)
Volume 1 issue 3, 2005. Homocysteine Metabolism. 5th International Conference, Milan, Italy, June 26-30, 2005. (Guest Editor: Marco Cattaneo)
Volume 1 issue 4, 2005. Nordic von Willebrand Workshop 2004. (Guest Editor: Stefan Lethagen)
Volume 1 issue 5, 2005. International Symposium on Infection-Driven Lymphomas, Rome, April 17-19, 2005
(Guest Editor: Giuseppe Leone)
Volume 1 issue 6, 2005. Von Willebrand Factor and von Willebrand disease: the state of the art in 2005.
(Guest Editors: P.M. Mannucci, F. Rodeghiero)
Volume 1 issue 7, 2005. Fourth International Symposium on Acute Promyelocytic Leukemia, Rome, September 29-October 1, 2005.
(Guest Editors: Francesco Lo Coco, Pier Giuseppe Pelicci)
Volume 1 issue 8, 2005. New Drugs in Hematology, Bologna, October 9-11, 2005.
(Guest Editors: Michele Baccarani, Giovanni Martinelli, Pier Luigi Zinzani)
Volume 1 issue 9, 2005. 3rd International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, October 14-16, 2005.
(Guest Editors: Anna Falanga, Benjamin Brenner, Frederick Rickles)
Volume 1 issue 10, 2005. Hemostasis and pregnancy, Milan, November 10, 2005. (Guest Editors: Francesco Baudo, Enrica Morra)
Volume 1 issue 11, 2005. Thalidomide in the treatment of multiple myeloma, Sydney, 10 April 2005. (Guest Editor: Douglas E. Joshua).
Volume 1 issue 12, 2005. Nodal aggressive non-Hodgkin’s lymphoma in the adult, Maurizio Martelli et al.